Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants [Phase 2]

View source ↗

Summary

This document outlines a Phase 2 pharmacokinetics, pharmacodynamics, safety and tolerability evaluation of CTAP101 extended-release capsules in pediatric partic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism
• Vitamin Deficiency

Drugs mentioned

• CTAP101 Extended-release Capsules

Snippet

Sponsor: OPKO Health, Inc. | Conditions: CKD Stage 3, CKD Stage 4 | Phase 2 | Status: NOT_YET_RECRUITING